BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9600228)

  • 1. Amyloid beta-protein (A beta) accumulation in the putamen and mammillary body during aging and in Alzheimer disease.
    Nakabayashi J; Yoshimura M; Morishima-Kawashima M; Funato H; Miyakawa T; Yamazaki T; Ihara Y
    J Neuropathol Exp Neurol; 1998 Apr; 57(4):343-52. PubMed ID: 9600228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-β42 in Alzheimer's disease.
    Shinohara M; Koga S; Konno T; Nix J; Shinohara M; Aoki N; Das P; Parisi JE; Petersen RC; Rosenberry TL; Dickson DW; Bu G
    Brain; 2017 Dec; 140(12):3301-3316. PubMed ID: 29161341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid beta-protein (A beta) accumulation in the leptomeninges during aging and in Alzheimer disease.
    Hamano T; Yoshimura M; Yamazaki T; Shinkai Y; Yanagisawa K; Kuriyama M; Ihara Y
    J Neuropathol Exp Neurol; 1997 Aug; 56(8):922-32. PubMed ID: 9258262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease.
    Kuo YM; Beach TG; Sue LI; Scott S; Layne KJ; Kokjohn TA; Kalback WM; Luehrs DC; Vishnivetskaya TA; Abramowski D; Sturchler-Pierrat C; Staufenbiel M; Weller RO; Roher AE
    Mol Med; 2001 Sep; 7(9):609-18. PubMed ID: 11778650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
    Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C
    Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural product extracts that reduce accumulation of the Alzheimer's amyloid beta peptide: selective reduction in A beta42.
    Yager D; Watson M; Healy B; Eckman EA; Eckman CB
    J Mol Neurosci; 2002; 19(1-2):129-33. PubMed ID: 12212770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A beta40 is a major form of beta-amyloid in nonhuman primates.
    Gearing M; Tigges J; Mori H; Mirra SS
    Neurobiol Aging; 1996; 17(6):903-8. PubMed ID: 9363802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression.
    Cummings DM; Liu W; Portelius E; Bayram S; Yasvoina M; Ho SH; Smits H; Ali SS; Steinberg R; Pegasiou CM; James OT; Matarin M; Richardson JC; Zetterberg H; Blennow K; Hardy JA; Salih DA; Edwards FA
    Brain; 2015 Jul; 138(Pt 7):1992-2004. PubMed ID: 25981962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression.
    Jensen M; Schröder J; Blomberg M; Engvall B; Pantel J; Ida N; Basun H; Wahlund LO; Werle E; Jauss M; Beyreuther K; Lannfelt L; Hartmann T
    Ann Neurol; 1999 Apr; 45(4):504-11. PubMed ID: 10211475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased cerebrospinal fluid A beta38/A beta42 ratio in Alzheimer disease.
    Mehta PD; Pirttila T
    Neurodegener Dis; 2005; 2(5):242-5. PubMed ID: 16909004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of sodium dodecyl sulfate-stable amyloid beta-protein dimers in the hippocampus CA1 not exhibiting neurofibrillary tangle formation.
    Funato H; Enya M; Yoshimura M; Morishima-Kawashima M; Ihara Y
    Am J Pathol; 1999 Jul; 155(1):23-8. PubMed ID: 10393832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapidly progressive Alzheimer's disease features distinct structures of amyloid-β.
    Cohen ML; Kim C; Haldiman T; ElHag M; Mehndiratta P; Pichet T; Lissemore F; Shea M; Cohen Y; Chen W; Blevins J; Appleby BS; Surewicz K; Surewicz WK; Sajatovic M; Tatsuoka C; Zhang S; Mayo P; Butkiewicz M; Haines JL; Lerner AJ; Safar JG
    Brain; 2015 Apr; 138(Pt 4):1009-22. PubMed ID: 25688081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The beta APP717 Alzheimer mutation increases the percentage of plasma amyloid-beta protein ending at A beta42(43).
    Kosaka T; Imagawa M; Seki K; Arai H; Sasaki H; Tsuji S; Asami-Odaka A; Fukushima T; Imai K; Iwatsubo T
    Neurology; 1997 Mar; 48(3):741-5. PubMed ID: 9065558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography.
    Palmqvist S; Mattsson N; Hansson O;
    Brain; 2016 Apr; 139(Pt 4):1226-36. PubMed ID: 26936941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
    Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
    Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to a 100-kd protein reveal abundant A beta-negative plaques throughout gray matter of Alzheimer's disease brains.
    Schmidt ML; Lee VM; Forman M; Chiu TS; Trojanowski JQ
    Am J Pathol; 1997 Jul; 151(1):69-80. PubMed ID: 9212733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer-type tau pathology in advanced aged nonhuman primate brains harboring substantial amyloid deposition.
    Oikawa N; Kimura N; Yanagisawa K
    Brain Res; 2010 Feb; 1315():137-49. PubMed ID: 20004650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laminar distribution of beta-amyloid deposits in dementia with Lewy bodies and in Alzheimer's disease.
    Armstrong RA
    Am J Alzheimers Dis Other Demen; 2006; 21(3):175-81. PubMed ID: 16869338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.
    Johnson-Wood K; Lee M; Motter R; Hu K; Gordon G; Barbour R; Khan K; Gordon M; Tan H; Games D; Lieberburg I; Schenk D; Seubert P; McConlogue L
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1550-5. PubMed ID: 9037091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.